Allegra Adele Petti, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Myeloid, Acute | 12 | 2022 | 3523 | 1.040 |
Why?
|
Sulfur | 3 | 2012 | 166 | 0.600 |
Why?
|
Methionine | 4 | 2012 | 590 | 0.540 |
Why?
|
Saccharomyces cerevisiae | 8 | 2012 | 2752 | 0.540 |
Why?
|
Sequence Analysis, RNA | 4 | 2019 | 2012 | 0.510 |
Why?
|
Bacillus Phages | 1 | 2013 | 12 | 0.480 |
Why?
|
Gene Expression Regulation, Fungal | 6 | 2012 | 502 | 0.430 |
Why?
|
Host-Parasite Interactions | 1 | 2013 | 295 | 0.390 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2012 | 315 | 0.380 |
Why?
|
Bacillus subtilis | 1 | 2013 | 359 | 0.370 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2183 | 0.360 |
Why?
|
RNA | 1 | 2019 | 2749 | 0.340 |
Why?
|
Saccharomyces cerevisiae Proteins | 6 | 2012 | 1888 | 0.330 |
Why?
|
Cell Division | 2 | 2013 | 4568 | 0.320 |
Why?
|
Myelodysplastic Syndromes | 4 | 2022 | 1352 | 0.320 |
Why?
|
Viral Proteins | 1 | 2013 | 1900 | 0.270 |
Why?
|
Azacitidine | 2 | 2017 | 347 | 0.250 |
Why?
|
Glioblastoma | 4 | 2023 | 3481 | 0.240 |
Why?
|
Antigens, Neoplasm | 3 | 2017 | 1988 | 0.230 |
Why?
|
Interleukin-15 | 2 | 2022 | 184 | 0.230 |
Why?
|
Mutation | 12 | 2021 | 29786 | 0.230 |
Why?
|
T-Box Domain Proteins | 1 | 2023 | 471 | 0.190 |
Why?
|
Genome, Fungal | 3 | 2012 | 204 | 0.180 |
Why?
|
Binding, Competitive | 1 | 2021 | 1157 | 0.180 |
Why?
|
Oxidative Stress | 1 | 2011 | 3086 | 0.180 |
Why?
|
SOXB1 Transcription Factors | 1 | 2021 | 284 | 0.180 |
Why?
|
Neuroma, Acoustic | 1 | 2024 | 451 | 0.180 |
Why?
|
Transcription Factors | 5 | 2023 | 12208 | 0.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2022 | 5442 | 0.160 |
Why?
|
Mitochondria | 1 | 2011 | 3520 | 0.160 |
Why?
|
Recurrence | 5 | 2022 | 8340 | 0.160 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3586 | 0.150 |
Why?
|
Genes, MHC Class II | 1 | 2018 | 457 | 0.150 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 2 | 2012 | 30 | 0.130 |
Why?
|
Gene Expression Profiling | 6 | 2019 | 9438 | 0.130 |
Why?
|
DNA-Binding Proteins | 2 | 2012 | 9648 | 0.130 |
Why?
|
Haploinsufficiency | 1 | 2017 | 328 | 0.130 |
Why?
|
Brain Neoplasms | 3 | 2022 | 8863 | 0.130 |
Why?
|
Immunotherapy, Active | 1 | 2015 | 60 | 0.130 |
Why?
|
Blood Cells | 1 | 2017 | 309 | 0.120 |
Why?
|
HLA-A2 Antigen | 1 | 2015 | 213 | 0.120 |
Why?
|
Immunity, Innate | 2 | 2023 | 2958 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4479 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 2 | 2017 | 3386 | 0.120 |
Why?
|
Immune System Diseases | 1 | 2016 | 262 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1381 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1209 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2016 | 640 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1241 | 0.110 |
Why?
|
Genes, Fungal | 2 | 2011 | 455 | 0.110 |
Why?
|
Chromosome Segregation | 1 | 2013 | 235 | 0.110 |
Why?
|
Microbial Viability | 1 | 2013 | 234 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1861 | 0.100 |
Why?
|
Point Mutation | 1 | 2017 | 1623 | 0.100 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2513 | 0.100 |
Why?
|
RNA Splicing | 1 | 2016 | 907 | 0.100 |
Why?
|
Epitopes | 1 | 2017 | 2571 | 0.090 |
Why?
|
Gene Expression | 2 | 2020 | 7799 | 0.090 |
Why?
|
Killer Cells, Natural | 3 | 2023 | 2133 | 0.080 |
Why?
|
Bone Marrow | 2 | 2016 | 2948 | 0.080 |
Why?
|
Glucose | 2 | 2011 | 4397 | 0.080 |
Why?
|
Transcription, Genetic | 4 | 2012 | 7722 | 0.080 |
Why?
|
Computational Biology | 2 | 2016 | 3521 | 0.080 |
Why?
|
Quantitative Trait Loci | 1 | 2016 | 2019 | 0.080 |
Why?
|
Phospholipids | 1 | 2011 | 784 | 0.080 |
Why?
|
Cancer Vaccines | 1 | 2015 | 1023 | 0.080 |
Why?
|
DNA Replication | 1 | 2013 | 1399 | 0.070 |
Why?
|
Phosphates | 1 | 2010 | 786 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2948 | 0.070 |
Why?
|
DNA Methylation | 1 | 2020 | 4286 | 0.070 |
Why?
|
Transcriptional Activation | 1 | 2011 | 1783 | 0.060 |
Why?
|
Ultrasonography | 1 | 2018 | 5985 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 12951 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4803 | 0.060 |
Why?
|
Phenotype | 2 | 2019 | 16365 | 0.060 |
Why?
|
Immunity | 2 | 2022 | 1012 | 0.060 |
Why?
|
Gene Deletion | 1 | 2012 | 2751 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3703 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2019 | 15519 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2015 | 2725 | 0.060 |
Why?
|
Humans | 22 | 2024 | 744343 | 0.060 |
Why?
|
Genomics | 1 | 2019 | 5720 | 0.060 |
Why?
|
Mice | 8 | 2023 | 81183 | 0.060 |
Why?
|
Schwann Cells | 1 | 2024 | 195 | 0.060 |
Why?
|
Cell Cycle | 1 | 2011 | 2967 | 0.050 |
Why?
|
Transplantation, Homologous | 2 | 2022 | 4776 | 0.050 |
Why?
|
Glycolysis | 1 | 2005 | 827 | 0.050 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10180 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6544 | 0.050 |
Why?
|
Meninges | 1 | 2022 | 190 | 0.050 |
Why?
|
Ecosystem | 1 | 2024 | 474 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2015 | 1791 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 706 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2023 | 810 | 0.040 |
Why?
|
Animals | 8 | 2023 | 168757 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 12072 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1878 | 0.040 |
Why?
|
Ubiquitination | 1 | 2021 | 1012 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2005 | 1889 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2023 | 1423 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2021 | 1655 | 0.040 |
Why?
|
Aging | 1 | 2015 | 8664 | 0.040 |
Why?
|
Melanoma | 1 | 2015 | 5510 | 0.040 |
Why?
|
Epitope Mapping | 1 | 2017 | 311 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2016 | 154 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2716 | 0.030 |
Why?
|
Idarubicin | 1 | 2015 | 62 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2018 | 769 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17446 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5686 | 0.030 |
Why?
|
Daunorubicin | 1 | 2015 | 158 | 0.030 |
Why?
|
Monitoring, Immunologic | 1 | 2015 | 100 | 0.030 |
Why?
|
Microglia | 1 | 2023 | 1266 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2017 | 1526 | 0.030 |
Why?
|
Mice, Mutant Strains | 1 | 2017 | 1866 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3597 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2018 | 1547 | 0.030 |
Why?
|
Cytarabine | 1 | 2015 | 692 | 0.030 |
Why?
|
Genome, Human | 2 | 2016 | 4420 | 0.030 |
Why?
|
Cell Line | 2 | 2017 | 15997 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4204 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2021 | 3772 | 0.030 |
Why?
|
Models, Genetic | 1 | 2002 | 3494 | 0.030 |
Why?
|
Myo-Inositol-1-Phosphate Synthase | 1 | 2011 | 2 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2023 | 3768 | 0.030 |
Why?
|
Galactokinase | 1 | 2011 | 16 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2765 | 0.030 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2012 | 168 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2015 | 805 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 3002 | 0.020 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 154 | 0.020 |
Why?
|
F-Box Proteins | 1 | 2012 | 197 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2072 | 0.020 |
Why?
|
S-Adenosylmethionine | 1 | 2011 | 212 | 0.020 |
Why?
|
Signal Transduction | 2 | 2024 | 23403 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 1692 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2017 | 1821 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4386 | 0.020 |
Why?
|
Oscillometry | 1 | 2010 | 147 | 0.020 |
Why?
|
Female | 8 | 2022 | 380194 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20822 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3479 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2015 | 1284 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
Methylation | 1 | 2011 | 1106 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 809 | 0.020 |
Why?
|
Macrophages | 1 | 2023 | 5655 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3638 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7322 | 0.020 |
Why?
|
Lymphocytes | 1 | 2016 | 2617 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5974 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11524 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2015 | 13033 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2020 | 9734 | 0.020 |
Why?
|
Ubiquitin | 1 | 2012 | 852 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 21683 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3647 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6895 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2015 | 4328 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11366 | 0.020 |
Why?
|
Chromatin | 1 | 2016 | 2934 | 0.020 |
Why?
|
Estradiol | 1 | 2011 | 2020 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2649 | 0.010 |
Why?
|
Binding Sites | 1 | 2012 | 6114 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1708 | 0.010 |
Why?
|
Male | 5 | 2018 | 350118 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12788 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6196 | 0.010 |
Why?
|
Cell Membrane | 1 | 2011 | 3748 | 0.010 |
Why?
|
Software | 1 | 2016 | 4443 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2011 | 3023 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5867 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9386 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19229 | 0.010 |
Why?
|
MicroRNAs | 1 | 2015 | 3752 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18029 | 0.010 |
Why?
|
Middle Aged | 3 | 2018 | 213383 | 0.010 |
Why?
|
Protein Interaction Mapping | 1 | 2002 | 627 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2010 | 2899 | 0.010 |
Why?
|
Adult | 3 | 2018 | 214055 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2016 | 12261 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5853 | 0.010 |
Why?
|
Aged | 2 | 2018 | 163280 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29063 | 0.010 |
Why?
|
Child | 1 | 2022 | 77709 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9583 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 53288 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 57776 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85781 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72290 | 0.010 |
Why?
|